4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001179110-19-008149
Director bought 16,200 shares at an average $23.10 ($374,280)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coleman Mark Director | 2019-06-25 | Purchase | +400 | $23.25 | $9,300 | 653,048 | D |
| Coleman Mark Director | 2019-06-26 | Purchase | +15,800 | $23.10 | $364,980 | 668,848 | D |
| Open-market purchases · 16,200 sh · avg $23.10 · $374,280 | |||||||
Loading xslF345X03/edgar.xml…